bmiMD vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
bmiMD beats MEDVi overall, scoring 8/10 vs 7.7/10. MEDVi is more affordable at $299/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of bmiMD and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
bmiMD
#9 of 40Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.
Visit bmiMDMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | bmiMD | MEDVi |
|---|---|---|
| Our Score | 8/10 | 7.7/10 |
| Starting Price | $319/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-first users who want affordable GLP-1 access | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #9 | #21 |
Pros & Cons Compared
bmiMD
Pros
- +Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
- +80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
- +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
- +HSA/FSA accepted for all programs
Cons
- −Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
- −$29.99 shipping fee per order — most competitors include free shipping
- −$50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
bmiMD edges out MEDVi with a score of 8/10 vs 7.7/10. If budget is your priority, MEDVi starts at $299/mo compared to bmiMD's $319/mo. bmiMD offers both brand-name and compounded medications, giving you more flexibility. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.